Researchers are investigating whether GLP-1 receptor agonists, commonly known as weight-loss drugs such as Ozempic and Wegovy, could help those with sleep apnea. Experts at the University of Pittsburgh reviewed the recent medical literature on the matter, aiming to address the question of whether these medications could specifically help individuals with obstructive sleep apnea, a …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.